Skip to main content

Peer Review reports

From: Spontaneous development of myasthenia gravis and myositis following treatment with pembrolizumab: a case report

Original Submission
14 Nov 2023 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
3 Dec 2023 Author responded Author comments - Maaria Chaudhry
Resubmission - Version 4
3 Dec 2023 Submitted Manuscript version 4
13 Dec 2023 Reviewed Reviewer Report - Edoardo Pronello
28 Mar 2024 Reviewed Reviewer Report
25 Apr 2024 Author responded Author comments - Maaria Chaudhry
Resubmission - Version 5
25 Apr 2024 Submitted Manuscript version 5
1 May 2024 Reviewed Reviewer Report
6 May 2024 Reviewed Reviewer Report
10 May 2024 Author responded Author comments - Maaria Chaudhry
Resubmission - Version 6
10 May 2024 Submitted Manuscript version 6
Publishing
20 May 2024 Editorially accepted
1 Jun 2024 Article published 10.1186/s12883-024-03684-2

You can find further information about peer review here.

Back to article page